Opendata, web and dolomites

DETRIMODE SIGNED

DEgradation TRIggered by MOdular DEsign

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DETRIMODE project word cloud

Explore the words cloud of the DETRIMODE project. It provides you a very rough idea of what is the project "DETRIMODE" about.

purinome    degradation    public    close    proximity    closer    environment    tpdis    solid    recruitment    prospects    protected    pursued    chance    mutual    peers    flexibility    exploited    progresses    ec    biology    ligands    speed    ubiquitin    inducers    stages    therapeutic    entities    society    multidisciplinary    innovation    outcomes    chemistry    affinity    synthetic    scope    methodology    molecular    computational    spacer    researcher    efficiency    synthesis    core    incrementing    bifunctional    engaged    ligase    molecule    influenced    apt    length    degradationtriggered    disease    molecules    structural    tackles    e3    variety    proteins    technologies    competence    series    designed    linker    grow    science    combinable    discovery    dept    tripartite    ligand    modular    updates    comprised    drugs    shared    organic    grafted    progressively    nms    ubiquitinating    intermediates    medchem    joined    proteasome    latter    articulated    small    oncology    endeavour    tpdi    arrays    cell    detrimode    chemical    composition    communicated    company    ternary    protein    driving   

Project "DETRIMODE" data sheet

The following table provides information about the project.

Coordinator
NERVIANO MEDICAL SCIENCES S.R.L 

Organization address
address: VIALE LUIGI PASTEUR 10
city: NERVIANO
postcode: 20014
website: www.nervianoms.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 168˙277 €
 EC max contribution 168˙277 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-SE
 Starting year 2018
 Duration (year-month-day) from 2018-05-21   to  2020-07-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    NERVIANO MEDICAL SCIENCES S.R.L IT (NERVIANO) coordinator 168˙277.00

Map

 Project objective

The project DETRIMODE (DEgradationTRIggered by MOdular Design) aims at the development of a methodology for the modular synthesis of Targeted Protein Degradation Inducers (TPDI), designed as bifunctional molecules apt to the degradation of target proteins via recruitment of the ubiquitin proteasome system, a process with therapeutic prospects if applied to disease driving proteins. TPDIs are comprised of an E3 ligase ligand and a target protein ligand joined by a spacer (linker), to bring the ubiquitinating system and the target protein in close proximity, so to promote degradation of the latter. The formation of the ternary complex (target protein-TPDI-E3 ligase) is an articulated process influenced by a series of factors, such as ligands affinity, linker length and composition and molecular features of the proteins involved. The project tackles this endeavour in stages of increasing innovation, progressively incrementing the scope, flexibility and efficiency of modular synthetic access to arrays of tripartite molecules via protected, solid grafted intermediates, combinable with a variety of target ligands. New chemical entities TPDIs will be generated targeting selected purinome proteins oncology-related. This project will be pursued within the Chemical Core Technologies Dept. of a fully integrated company (NMS), engaged in the discovery and development of new small molecule based drugs. Organic and solid phase chemistry, computational and structural chemistry, molecular and cell biology, among others, will be exploited to achieve the project’s goal. In such multidisciplinary environment, this new technology will grow at the same speed with the researcher’s medchem competence, increasing the chance of mutual success. DETRIMODE outcomes will be shared with peers, while updates on its progresses as well as general information on how EC-funded research have impact on the general public will be communicated by a number of means, bringing science closer to society

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DETRIMODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DETRIMODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More  

HSQG (2020)

Higher Spin Quantum Gravity: Lagrangian Formulations for Higher Spin Gravity and Their Applications

Read More  

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More